fABMACS allows scientists to better harness the power of existing software while greatly improving their ability to predict the way that a potential drug interacts with a protein
By creating a cell model of medulloblastoma from human cells rather than working with mouse cells, the researchers say they can be more confident that patients’ response to the drugs identified in the screenings may be more comparable to humans